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Abstract The disaccharide trehaiose plays a critical role in 
yeast cell survival during conditions of environmental stress. The 
vacuole of the yeast Saccharomyces cerevisiae contains an 
enzyme, acid trehalase (ATH), that is capable of degrading 
trehalose. Recently, a gene required for ATH activity, A TH1, 
was cloned and sequenced [DestrueHe et al., (1995) Yeast 11, 
1015-1025]. The relationship between A TH1 and ATH, however, 
was not determined. We have purified ATH and shown that it is 
the ATH1 gene product; peptide sequences from the purified 
protein correspond to the deduced amino acid sequence of Athlp. 
In addition, antiserum to Athlp specifically recognizes purified 
ATH. 
Key words: Acid trehalase; ATH1 gene; Trehalose; 
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1. Introduction 
Of the many physiological processes associated with the 
yeast vacuole, its degradative capacity is the most thoroughly 
characterized [24]. The numerous hydrolytic enzymes loca- 
lized to this organelle play a role in the breakdown and turn- 
over of a wide range of metabolites. The vacuole also serves 
as a site for the recycling of subcellular organelles [5,6]. In 
either case, the proteins or membrane-bound compartments 
destined for degradation eed to enter the vacuole lumen 
where they become accessible to the reduced pH and hydro- 
lytic environment. Following hydrolysis, the macromolecular 
constituents are either stored within the vacuole or released 
into the cytosol to be used in metabolic reactions. 
Due to their potential degradative capacity, many vacuolar 
hydrolases are synthesized as precursor proteins that require 
proteolytic maturation and/or an acidic pH for optimal activ- 
ity [7]. In some cases, other aspects of the vacuolar milieu 
such as the salt concentration may enhance the hydrolytic 
capacity [8]. These factors along with the compartmentaliza- 
tion of these enzymes within the organelle allow the hydro- 
lases to be separated from potential substrates; this sequestra- 
tion essentially serves a regulatory role by limiting potential 
enzymatic reactions. Astonishingly little is known, however, 
regarding the mechanisms by which metabolites are delivered 
to the vacuole and even less is understood about the efflux 
processes. 
Carbohydrate metabolism provides one example of an im- 
portant physiological process that is poorly characterized with 
respect to the vacuole. ¢t-mannosidase (AMS) is the only 
known general glycosidase localized to the vacuole. In addi- 
tion to AMS, the vacuole contains at least one other glycosi- 
dase, the acid trehalase (ATH). Relatively little research as 
focused on the biosynthesis of this enzyme. ATH is reported 
to transit hrough the secretory pathway [9,10], and its activity 
is dependent on the activity of PrA [11]. ATH is of particular 
interest because its substrate, trehalose, plays an important 
role as a membrane protectant under stress conditions [12- 
15]. Again, there are more questions than answers concerning 
the function of ATH in cellular physiology. To further under- 
stand the possible role of this enzyme in trehalose metabolism, 
Mittenbfihler and Holzer purified the enzyme [16] and at- 
tempted to study its biosynthesis. Even though they achieved 
an over 7000-fold purification of ATH activity, it appears that 
they copurified an additional protein. This highly glycosylated 
protein, gp37 [17], was most likely the protein characterized in 
an earlier study [9]. 
Recently, we undertook an alternative approach to charac- 
terize ATH by first identifying the structural gene. We took 
advantage of the observation that the overproduction of pro- 
teins that transit hrough the secretory pathway leads to their 
expression at the cell surface [18,19]. Relying on an assay to 
detect surface acid trehalase activity, we cloned a gene termed 
ATH1 that is required for ATH activity [1]. Surprisingly, 
analysis of the deduced amino acid sequence of the A TH1 
gene failed to reveal homology to trehalases or the presence 
of a consensus ignal sequence cleavage site [20]. These find- 
ings made it unclear whether the A TH1 gene was the structur- 
al gene for ATH or whether it encoded a regulatory factor. To 
differentiate between these possibilities, and to gain further 
insight concerning the role of ATH in regulating the cellular 
levels of trehalose, we purified the acid trehalase. Peptide se- 
quences from ATH match the deduced amino acid sequence 
of the A TH1 gene. In addition, antiserum raised to a TrpE- 
A TH1 hybrid protein recognizes the purified ATH protein. 
These results indicate that ATH1 is the structural gene for 
ATH (see also [21]). 
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2. Materials and methods 
Abbreviations: ATH, acid trehalase; Endo H, endo-[~-N-acetylgluco- 
saminidase H; IEF, isoelectric focusing; NTH, neutral trehalase; 
PIPES, piperazine-N,N'-bis(2-ethanesulfonic acid); PrA, proteinase A;
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophor- 
esis; YNB, yeast nitrogen base; YPD, 1% bacto-yeast extract, 2% 
bacto-peptone, 2% dextrose 
2.1. Strains and media 
The strains of Saccharomyces cerevisiae used in this study were 
SEY6210 (MATs ura3-52 leu2-3,112 his3-A200 trpl-A902 lys-801 
suc2A9) [22]; MDY1 (SEY6210 Aygpl::URA3) [17]; MDY3 
(SEY6210 Aathl::URA3) [1]. The acid trehalase-overproducing strain 
was prepared by transforming wild-type strain SEY6210 with the 2Ix 
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overproducing plasmid pDAT1.9, which carries the ATH1 gene [1]. 
This strain is referred to as SEY6210/pDAT1.9 throughout this paper. 
Yeast cells were grown in YPD or synthetic minimal medium 
(0.067% yeast nitrogen base (YNB), 2% glucose, and auxotrophic 
amino acids and vitamins as needed). 
2.2. Antibody generation and imrnunodetection 
A XhoI-SalI restriction fragment encoding 42% of the A TH1 open 
reading frame was isolated from plasmid pDAT1.9 and cloned in- 
frame into the vector pATH2 [23] at the unique SalI site to create a 
TrpE-A TH1 gene fusion. Hybrid protein was overproduced in E. eoli 
and partially purified using described techniques [23]. Preparative 
quantities of the proteins were solubilized and further purified using 
SDS-PAGE. Gel slices containing the band of interest were excised, 
homogenized and used for immunization of New Zealand white rab- 
bits. Western blots and chemiluminescent detection of proteins were 
carried out essentially as described [24]. Antiserum to Athlp was used 
at a dilution of 1:10000. Goat anti-rabbit antibodies were purchased 
from Bio-Rad Laboratories (Hercules, CA). 
2.3. Assays 
To assay for acid trehalase activity, yeast cells (132 000 A600 units) 
were grown in YPD or SMD, harvested by centrifugation and lysed 
with glass beads. A crude cell extract was prepared by centrifugation 
of lysed cells at 10000×g for 60 min and discarding the pellet frac- 
tion. Acid trehalase was assayed by incubating 20 I.tl of diluted (1:100) 
crude extract in a reaction mixture containing 40 mM sodium citrate, 
pH 4.5, 1 mM EDTA and 200 mM trehalose in a total volume of 250 
I11 in a microcentrifuge tube. After 30 min of incubation at 37°C, the 
reaction was stopped by adding 300 ~tl of 0.1 M KH~PO4, pH 10, and 
boiling the mixture for 3 rain, followed by a high-speed centrifugation 
at 13 000 x g for 5 min. The glucose concentration was determined 
enzymatically as described previously [25]. One activity unit of acid 
trehalase isdefined as the amount of enzyme that catalyzes the hydro- 
lysis of 1 lxmol of trehalose/min at 37°C at pH 4.5. 
Assays for the marker enzymes c~-mannosidase, c~-glucosidase and 
NADPH-cytochrome e reductase were performed as described pre- 
viously [25]. Protein concentrations were determined using the com- 
mercial BCA protein assay (Pierce Chemical Co, Rockford, IL) with 
bovine serum albumin, fraction V as the standard. 
2.4. Purification of ATH 
Purification of ATH was carried out essentially using the procedure 
of Mittenbiihler and Holzer [16]. Modifications are described below: 
Crude extract: SEY6210/pDAT1.9 yeast cells were grown in YPD 
to an Ar00 ~ 11.0, harvested by centrifugation (300 g wet weight from 
12 1 of culture medium), washed twice with buffer A (40 mM sodium 
citrate, pH 4.5, 1 mM EDTA), and resuspended in 550 ml lysis buffer 
(440 ml buffer A, 110 ml glycerol) containing 1mM PMSF. Cells were 
disrupted using an Eaton press (American Instrument Co., Silver 
Spring, MD) at 20 000 lb/inch 2. 
Hydrophobic interaction chromatography: Fractions with highest 
activity were pooled, and desalted by passage through a Sephadex G- 
25 column (1.5 cm× 100 cm). 
Gel filtration chromatography: The protein solution obtained from 
the previous tep was loaded on a Superose 12 gel filtration column 
(HR 10/30; Pharmacia, Piscataway, NJ), equilibrated with buffer B 
(40 mM sodium citrate, 1 mM EDTA, pH 4.5). Acid trehalase was 
eluted from the column using buffer B. Fractions with highest ATH 
activity were pooled, stored on ice and precipitated with 80% ethanol 
(final concentration) for 12-18 h at 0°C. The precipitate was dissolved 
in distilled H20. 
Preparative isoelectric focusing: The protein solution (1.0 mg) ob- 
tained from the Superose 12 purification step was injected into a 
prefocused standard Biolyte-filled chamber of a Rotofor preparative 
isoelectric focusing system (BioRad, Hercules, CA) in a narrow pH 
gradient range, pH 3.9-5.6. Fractions were simultaneously aspirated 
into 20 individual test tubes (1 ml/tube) and each fraction was assayed 
for ATH activity. The Rotofor purification resulted in an apparent 
decrease in the fold purification due to dilution (Table 1). This step, 
however, allowed the resolution of the ATH band from a contami- 
nant of lower molecular mass (approx. 33 kDa; Fig. 1, lane 4). 
2.5. Deglycosylation by endoglycosidase H 
Acid trehalase was denatured at 95°C for 10 min in 0.1 M sodium 
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acetate, pH 5.5, 0.5% SDS, 0.5% [3-mercaptoethanol. The denatured 
protein was then treated with endo H (Boehringer Mannheim Bio- 
chemicals, Indianapolis, IN; 0.5 mUll I.tg protein for 2-4 h at 37°C) 
in endo H buffer (50 mM sodium citrate, pH 5.5). 
2.6. Proteinase digestion and peptide sequencing 
The deglycosylated purified ATH protein was transferred to PVDF 
membrane (Immobilon-P: Millipore Corp., Bedford, MA) and di- 
gested with endopeptidase Lys-C. Peptide fragments were resolved 
by HPLC. Two peptides were sequenced by automated Edman degra- 
dation, with subsequent identification of the PTH-amino acids by 
HPLC. 
3. Results 
3.1. Purification of  acid trehalase 
As a first step in the characterization of the vacuolar acid 
trehalase (ATH), we decided to purify the enzyme and deter- 
mine if it is the product of the ATH1 gene. ATH activity co- 
purifies with the secreted enzyme invertase [16]. To reduce the 
possibility of  contaminants in the purification procedure, we 
initially carried out a small scale preparation utilizing a yeast 
strain, MDY3 [1], having disruptions in both the SUC2 and 
YGP1 genes (data not shown). After identifying the ATH 
protein, free of the known invertase and gp37 contaminants, 
the purification was repeated on a larger scale starting with a 
strain that overproduced ATH from a multi-copy plasmid 
(SEY6210/pDAT1.9). Table 1 summarizes the purification of 
ATH from this strain. We achieved a 37% yield with approx. 
600-fold purification. The apparent increase in ATH activity 
following the first two steps of purification, i.e. the citric acid 
and ammonium sulfate fractionation steps, may represent ac- 
Protein: STDI INV ] ATH 
Endo H: - + - + 
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Lane:  1 2 3 4 5 
Fig. 1. ATH is a glycoprotein. Purified ATH and commercially pu- 
rified invertase were deglycosylated with endo H as indicated, run 
on an SDS polyacrylamide gel and detected by staining with Coo- 
massie Blue. Lanes: 1, molecular weight standards; 2, 35 ~tg of gly- 
cosylated invertase; 3, 35 p.g of deglycosylated invertase; 4, 6 I.tg of 
Superose 12 purified ATH; 5, 6 Ixg of Superose 12 purified, deglyco- 
sylated ATH. The positions of deglycosylated invertase and deglyco- 
sylated ATH are indicated. - ,  sample without endo H treatment; 
+, sample treated with endo H. 
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Fig. 2. Isoelectric focusing of acid trehalase. 1.0 Ixg of ATH from the Rotofor purification step was run on the Pharmacia PhastSystem. The 
standard protein markers and their pI values are: (a) soybean trypsin inhibitor (4.55), (b) I]-lactoglobulin A (5.20), (c) bovine carbonic anhy- 
drase B (5.88), (d) human carbonic anhydrase B (6.55). (A) Coomassie Blue-stained IEF gel of ATH and of marker protein. The pH profile of 
the gel is indicated based on the migration position of the protein standards. The position of ATH is indicated and the dotted line marks the 
calculated pL (B) An identical sample of ATH was run on the IEF gel. The gel was sliced into sections, homogenized and assayed for ATH ac- 
tivity as described in Section 2. The ATH activity profile of the homogenized gel slices is shown. ATH activity is expressed as nmol glucose re- 
leased/gel s ice per 30 min. 
tivated latent activity; cytosolic inhibitors have been charac- 
terized for several vacuolar hydrolases [26]. 
3.2. Properties of the purified acid trehalase 
The purified enzyme xhibited a broad smear corresponding 
to a molecular mass in the range of 143-203 kDa above a 
sharply defined band (Fig. 1, lane 4). The molecular mass of 
ATH was estimated to be 210 kDa by high-performance g l 
filtration (data not shown). This is in agreement with the size 
of ATH estimated previously by others [16,27]. The purified 
glycosylated ATH preparation contains an additional band 
migrating at approx. 33 kDa (Fig. 1). This lower molecular 
weight band does not fractionate with ATH activity following 
purification by isoelectric focusing (data not shown). Lane 4 
of Fig. 1 represents a pooled set of fractions that include this 
lower molecular weight species. The pH optimum of the pu- 
rified enzyme was found to be approx. 4.0 in the crude ex- 
tract, as well as in the purified protein preparation (data not 
shown). This pH activity profile also fits well with published 
data [16,27]. 
3.3. ATH is a glycoprotein 
The migration pattern of the purified enzyme is typical of 
proteins that undergo heterogeneous glycosylation and sug- 
gests that ATH is a glycoprotein. It is worth noting, however, 
that this type of glycosylation is not seen with any previously 
characterized vacuolar hydrolases; vacuolar glycoproteins 
generally undergo limited glycosyl modification, resulting in 
sharply defined bands on SDS-PAGE gels [25,28-30]. In con- 
trast, secreted proteins including invertase tend to run as a 
smear under identical conditions ([31]; Fig. 1, lane 2). Incuba- 
tion of the ATH preparation with Concanavalin A-Sepharose 
removed all ATH activity from the supematant (data not 
shown), further confirming that ATH is a glycoprotein. 
To determine the size of the deglycosylated protein, the 
carbohydrate moieties were removed from the Superose 12- 
purified ATH preparation using endo H. SDS-PAGE revealed 
the presence of a doublet at approx. 85 kDa, a 31 kDa species 
and an additional band migrating at approx. 37 kDa (Fig. 1, 
lane 5). The band migrating at approx. 31 kDa is probably the 
deglycosylated form of the 33 kDa contaminant. Analysis of 
the ATH preparation from the Aygpl strain showed only the 
85 and 31 kDa bands (data not shown), suggesting that the 37 
kDa species is the deglycosylated YGP1 gene product, gp37. 
While it is possible that the highly glycosylated 85 kDa species 
corresponds to a copurifying contaminant protein, the lack of 
additional bands other than gp37 and the 31 kDa protein 
following deglycosylation suggests that this highly glycosy- 
lated protein is ATH. 
To ascertain the identity of the doublet at approx. 85 kDa, 
the ATH preparation was further fractionated on an isoelec- 
tric focusing gel (Fig. 2). The ATH preparation was run in 
two parallel lanes and the gel was divided in half. One half of 
the gel was stained with Coomassie Blue to allow a determi- 
nation of the isoelectric point. The remaining half of the gel 
was cut into thin horizontal pieces, ground up and again 
divided into two samples. One sample was used to measure 
ATH activity. The peak ATH activity (Fig. 2A) coincided 
with a Coomassie Blue stained doublet band migrating in 
the pH zone of 4.8 (Fig. 2B). An isoelectric point of 4.8 is 
in close agreement with the previously reported p I  for ATH 
[16]. The remaining sample from the homogenized gel slice 
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Deduced Athlp:  
Pur i f ied  ATH: 
P.A~adeh, D.Z Klions~/FEBSLet~rs391(1996) 2 ~  
238 Tyr  G lu  Asn  Ser Thr Asn  Pro I le Asn  Ser Set G lu  Ser Phe 251 
Tyr  G lu  --- Ser Thr  Asn  Pro I le Asn  Ser --- G lu  Phe 
Deduced Athlp:  255 Asp  Val  Ser Ser Asn  I le Tyr  Ash  Val  I le Leu Thr  266 
Pur i f ied  ATH: Asp  Va l  Ser Ser Asn  I le Tyr  Asn  I le --- Thr  
Fig. 3. ATH is the ATH1 gene product. The deglycosylated purified ATH was subjected to endoproteinase Lys-C digestion and Edman degra- 
dation as described in Section 2. The amino acid sequence was determined from an internal peptide of both the upper and lower bands of the 
ATH doublet (see Fig. 1). The amino acid sequences are shown below the corresponding deduced sequences from the ATH1 gene. The numbers 
indicate the position of residues in Athlp [1]. The upper and lower peptides correspond to amino acid sequences from the upper and lower 
bands of the doublet, respectively. 
corresponding to the peak ATH activity was subjected to 
endo H treatment. SDS-PAGE analysis revealed a doublet 
migrating at 85 kDa (data not shown). A similar doublet 
band of approx. 85 kDa which corresponds to ATH was 
also seen by Mittenbtihler and Holzer after deglycosylation 
of their purified protein preparation ([9]; Fig. 1). However, 
they analyzed the 37 kDa protein (now known to represent 
gp37 [17]) as ATH instead of the 85 kDa band. These results 
suggest hat the 85 kDa deglycosylated species correspond to 
ATH. 
3.4. Amino acid analysis confirms that ATH1 encodes ATH 
The A TH1 gene encodes a protein with a predicted mo- 
lecular mass of 117 kDa. Many vacuolar hydrolases are initi- 
ally synthesized as larger zymogens that are processed to an 
active form upon delivery to the vacuole [7]. Similarly, ATH 
activity is reported to be dependent on the PEP4 gene pro- 
duct, PrA [11]. To further define the relationship between the 
ATH1 gene and the 85 kDa protein(s) in the deglycosylated 
ATH preparation, we determined the amino acid sequence 
from internal peptide fragments from each band in the dou- 
blet. The doublet bands were resolved on an 8% polyacryl- 
amide gel, transferred to PVDF, cleaved with protease and 
subjected to Edman degradation as described in Section 2. 
The sequenced peptides aligned completely with the deduced 
amino acid sequence from the A TH1 gene (Fig. 3); the se- 
quences of peptides from the upper and lower bands corre- 
sponded to residues 238-251 and 255-266 of the deduced 
Athlp sequence, respectively. Both the upper and lower bands 
from the doublet are derived from ATH1, suggesting that the 
lower species may be a degradation product. Both species 
showed very similar peptide profiles on HPLC following en- 
doproteinase Lys-C digestion (data not shown), providing a 
further indication that they are derived from a common poly- 
peptide. Finally, the two bands have almost identical isoelec- 
tric points (Fig. 2). The N terminus of the upper band was 
found to be blocked, making it impossible to determine if 
there is an N-terminal propeptide cleavage site. 
3.5. Antiserum to Athlp specifically detects ATH 
As a further test of the relationship between ATH and the 
ATH1 gene product, we generated antiserum to a TrpE-ATH1 
hybrid protein as described in Section 2. Crude extracts were 
prepared from wild-type, Aathl and the ATH overexpressing 
strains of yeast. The extracts were taken through the ammo- 
nium sulfate fractionation step and then desalted to partially 
purify the ATH protein. The samples were resolved by SDS- 
PAGE and proteins were detected by immunoblot. Antiserum 
to Athlp detects a protein of approx. 85 kDa in a wild-type 
yeast strain but not in an isogenic Aathl strain, indicating that 
the antiserum is specific to ATH (Fig. 4). Overexpression of
ATH activity on a multi-copy plasmid results in an increased 
level of protein detectable with the antiserum to Athlp, pro- 
viding additional confirmation that ATH is the A TH1 gene 
product. 
4. Discussion 
The yeast S. cerevisiae contains two enzymes capable of 
degrading the disaccharide trehalose. The gene encoding the 
neutral cytosolic trehalase, NTH1 [32], has been cloned and 
the gene product identified [33]. In contrast, much less is 
known about the vacuolar acid trehalase. Previous studies 
of ATH have been hampered by the copurification of this 
enzyme with other proteins. It is not known why the highly 
glycosylated proteins invertase and gp37 copurify with ATH. 
Possibly ATH binds these proteins due to its nature as a 
glycosidase. Alternatively, ATH may itself be highly glycosy- 
lated giving it similar properties with regard to purification. 
Recently, we identified a gene, A TH1, that is required for 
ATH activity [1]. The lack of a consensus ignal sequence 
cleavage site and the absence of homology to known treha- 
lases, however, made it unclear as to whether A TH1 was the 
structural gene for ATH, or whether it encoded a regulatory 
protein. To clarify the relationship of ATH1 to ATH we pu- 
rified the vacuolar acid trehalase (ATH) activity. After pur- 
ification of ATH, we determined the partial amino acid se- 
Table 1 
Purification of acid trehalase 
Step Volume (ml) Total activity (units) Specific activity Purification (-fold) Yield (%) 
(units/mg) 
1. Crude extract 620 2728 0.2 1 100 
2. Citric acid 590 3737 2 10 137 
3. Ammonium sulfate 700 4317 23 115 158 
4. Spherogel 102 2400 109 545 88 
5. Sephadex G-25 105 1866 110 550 68 
6. Superose 12 8 1083 119 595 40 
7. Rotofor 10 1020 113 565 37 
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quence of the trehalase protein. We found a perfect match 
between the sequences in ATH and deduced sequences in 
ATH1. In addition, antiserum raised to a TrpE-ATH1 hybrid 
protein specifically recognized the purified ATH protein, 
further indicating that ATH is the A TH1 gene product. 
ATH activity has been localized to the vacuole [27] and is 
reported to be dependent on the PEP4 gene product PrA [11]; 
there is a 4-fold reduction in ATH activity in a Apep4 strain. 
We have observed a similar eduction in ATH activity in pep4 
strains (data not shown). The reported PEP4 dependence of
ATH activity [11] suggests the presence of a propeptide that is 
cleaved in the vacuole by PrA or a PrA-dependent hydrolase 
such as PrB, This is consistent with the fact that the 85 kDa 
ATH is substantially smaller than the potential 117 kDa pro- 
tein encoded by the A TH1 open reading frame. A 30 kDa 
peptide would be large but is approximately the size of the 
N-terminal propeptide of the vacuolar hydrolase proteinase B 
[30]. Because our antiserum to Athlp only detects ATH in 
western blots and not by immunoprecipitation, we are not 
able to carry out a kinetic analysis to directly demonstrate 
processing of the enzyme. Purification of ATH from a 
Apep4 strain revealed a band that co-migrated with ATH 
from a wild-type strain (data not shown). We think it likely, 
however, that the labile propeptide was degraded uring the 
purification procedure. 
The cytosolic neutral trehalase is subject o phosphoryla- 
tion-dependent activation while ATH is constitutively active 
[34,35]. This differential regulation is necessary because treha- 
lose lines the plasma membrane where it would be exposed to 
neutral trehalase; ATH activity is sequestered within the va- 
cuole. The role of ATH in trehalose metabolism is not under- 
stood. The enzyme is synthesized as cells exit from logarithmic 
phase growth [36] at the same time that trehalose accumulates 
[37]. ATH may play a role in mobilization of trehalose upon 
return to vegetative growth conditions. Catabolite inactiva- 
tion of the trehalose synthesizing enzymes occurs in the pre- 
sence of glucose [38]. Once the synthesizing enzymes are de- 
stroyed, the conditions presumably warrant the eventual 
degradation of trehalose as well, although the timing of these 
two events has not been correlated. 
Another question that remains unanswered is the mechan- 
ism by which trehalase gains access to its substrate. Both 
endocytosis and autophagy are general mechanisms used for 
vacuolar delivery of extracellular and cytoplasmic onstitu- 
ents, respectively, prior to degradation. In the case of endo- 
cytosis, the specific signals that trigger inclusion of proteins 
into endocytic vesicles are at best partly understood for a 
limited number of proteins. Trehalose could be internalized 
from the cell surface and delivered to the vacuole via endocy- 
tosis. Autophagy is even less well characterized but could be 
used for the vacuolar uptake of cytosolic trehalose. A plasma 
membrane trehalose transporter has been shown to be in- 
volved in the extracellular localization of the disaccharide 
[39]. It is not known whether a similar transport mechanism 
exists in the vacuole membrane. Whichever the case, the sig- 
nals that might trigger trehalose uptake into the vacuole are 
not known. Our identification of A TH1 as the gene encoding 
ATH allows us to address questions of trehalose metabolism 
by focusing on the biosynthesis of the vacuolar acid trehalase 
and the regulation of the A TH1 gene. 
After preparing this manuscript, a paper from the group of 
H. Holzer was published [21] which showed ATH as necessary 
2g 
ATH Aathl WT ATH 
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ATH 
Lane: 1 2 3 4 
Fig. 4. Antiserum to Athlp specifically detects ATH. ATH was pu- 
rified through step 3 of the purification procedure as described in 
Section 2 (see Table 1) from the Aathl (MDY3), wild-type 
(SEY6210) and A THI-overproducing (SEY6210/pDAT1.9) strains. 
Following desalting, the ATH preparations were deglycosylated with 
endo H. Partially purified, deglycosylated ATH was subjected to 
SDS PAGE, transferred to PVDF membrane and probed with anti- 
serum to Athlp. Signals were detected using chemiluminescence. 
Lanes: 1, 0.5 gg purified ATH from the Rotofor step; 2, 5 gg of 
protein from the Aathl strain; 3, 5 gg of protein from the wild-type 
strain; 4, 5 gg of protein from the overproducing strain. 
for utilization of extracellular t ehalose and demonstrated a 
gene dosage effect of the ATH1 gene for ATH activity and 
growth on trehalose. These data provide the first information 
on the physiological role of vacuolar acid trehalase. 
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